Cadila Healthcare informs about press release

05 Feb 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated February 5, 2021 titled ‘Zydus completes large scale enrolment for two Phase III trials of Desidustat’. The contents of the press release give full details. Bring the aforesaid news to the notice of the members of the exchange and the investors at large.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

895.00 0.05 (0.01%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1736.85
Dr. Reddys Lab 1215.65
Cipla 1466.05
Zydus Lifesciences 895.00
Lupin 2189.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×